Adamas Pharmaceuticals
ADMS
#7205
Rank
โ‚ฌ0.33 B
Marketcap
7,41ย โ‚ฌ
Share price
0.00%
Change (1 day)
15,865.02%
Change (1 year)

Earnings for Adamas Pharmaceuticals (ADMS)

Earnings in 2021 (TTM): -โ‚ฌ32.29 Million

According to Adamas Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ88.18 Million. In 2020 the company made an earning of -โ‚ฌ39.56 Million, an increase over its 2019 earnings that were of -โ‚ฌ81.3 Million.

Earnings history for Adamas Pharmaceuticals from 2013 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-โ‚ฌ32.29 Million-18.38%
2020-โ‚ฌ39.56 Million-51.34%
2019-โ‚ฌ81.3 Million-19.45%
2018-โ‚ฌ0.11 Billion28.96%
2017-โ‚ฌ78.26 Million42.3%
2016-โ‚ฌ55 Million6.18%
2015-โ‚ฌ51.8 Million-410.24%
2014โ‚ฌ16.69 M-67.53%
2013โ‚ฌ51.41 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.2 Billion 448.89%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ88.25 M-353.36%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.35 B-9,719.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ3.96 B-11,476.27%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ19.12 B-54,999.17%๐Ÿ‡บ๐Ÿ‡ธ USA